S&P Futures
3,902.00 +4.25 (+0.11%) Dow Futures
31,241.00 +39.00 (+0.12%) Nasdaq Futures
11,838.00 -40.25 (-0.34%) Russell 2000 Futures
1,771.50 -3.40 (-0.19%) Crude Oil
110.35 +0.46 (+0.42%) Gold
1,845.10 +3.90 (+0.21%)
Insmed Incorporated (INSM)
After hours:
Chart Events
Performance Outlook
| Previous Close | 19.57 |
| Open | 19.98 |
| Bid | 18.40 x 3100 |
| Ask | 25.00 x 3200 |
| Day's Range | 19.33 - 20.27 |
| 52 Week Range | 16.41 - 34.44 |
| Volume | |
| Avg. Volume | 1,085,611 |
| Market Cap | 2.397B |
| Beta (5Y Monthly) | 2.15 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.92 |
| Earnings Date | Feb 23, 2022 - Feb 28, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 49.90 |
- PR Newswire
Insmed Names Drayton Wise Chief Commercial Officer
Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the appointment of Drayton Wise as Chief Commercial Officer, effective May 23, 2022. In addition to his current responsibilities leading the global ARIKAYCE® (amikacin liposome inhalation suspension) franchise and U.S. commercial activities, Mr. Wise will assume responsibility for all of Insmed's global commercial functions. Mr. Wi
- PR Newswire
Insmed Presents New Data Across Three Pillars at American Thoracic Society 2022 International Conference
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today reported data from seven presentations across three of its pillars—ARIKAYCE, brensocatib, and treprostinil palmitil inhalation powder (TPIP)—at the American Thoracic Society (ATS) 2022 International Conference.
- PR Newswire
Insmed To Present at the H.C. Wainwright Annual Global Life Sciences Conference
Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present in a fireside chat at the H.C. Wainwright Annual Global Life Sciences Conference.
